Predictors of change in hypoglycemia unawareness among patients with type 1 diabetes

Jared Melnychuk1, Kathleen Wyne2, Kathleen Dungan2

  • 1The Ohio State University College of Medicine, Columbus, Ohio, USA.

Insights

Hypoglycemia unawareness (HU) in type 1 diabetes is predicted by diabetes duration, gender, and kidney function. Improvement in HU is achievable, even in long-standing cases, warranting further investigation.

Area of Science:

  • Endocrinology
  • Nephrology
  • Metabolic Disorders

Background:

  • Hypoglycemia unawareness (HU) is a significant complication in type 1 diabetes (T1D), increasing the risk of severe hypoglycemia.
  • Predictors of HU and the potential for improvement in clinical practice require further elucidation.

Purpose of the Study:

  • To identify predictors of hypoglycemia unawareness (HU) in patients with type 1 diabetes (T1D).
  • To analyze factors associated with improvement in the Clarke score, a measure of HU, in a clinical setting.

Main Methods:

  • Retrospective analysis of 300 T1D patients from an academic clinic who completed HU surveys.
  • Assessment of HU (Clarke score ≥4) and score improvement (≥1 or ≥2 points) using univariable and multivariable logistic regression.

Main Results:

  • Male gender, longer diabetes duration, and reduced estimated glomerular filtration rate (eGFR <60 ml/min/1.73 m²) were independent predictors of baseline HU.
  • Continuous glucose monitoring use and longer diabetes duration predicted a 1-point improvement in Clarke score.
  • Reduced eGFR and attending an education visit predicted a 2-point improvement in Clarke score.

Conclusions:

  • Diabetes duration, gender, and eGFR are key independent predictors of HU in T1D.
  • Improvements in HU, as measured by the Clarke score, are attainable in patients with long-standing T1D.
  • Further research is needed to optimize HU management strategies in T1D.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
314
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
657
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
337
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.5K